Blauvelt, A, RB Warren, K Reich, F Brock, F Fierens, V Ciaravino, and M Lebwohl. 2021. “Durability of DLQI Improvements Among Patients With Moderate to Severe Plaque Psoriasis Treated With Certolizumab Pegol: Three-Year Results from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)”. SKIN The Journal of Cutaneous Medicine 5 (1):s19. https://doi.org/10.25251/skin.5.supp.19.